BB

Bindi Binoy Palkhiwala

Active Director Designated Partner DIN 10011889
DIN 10011889 First appointment Jul 2022 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Bindi Binoy Palkhiwala

Data last updated:

Bindi Binoy Palkhiwala is a Designated Partner at Aryav Superspeciality Hospital Llp (since 2022). The company operates in Healthcare.

DIN 10011889
Primary Designation Designated Partner
Industry Healthcare
First Appointment 20 Jul 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner20 Jul 20222022Active

Board colleagues of Bindi Binoy Palkhiwala

NameDINCompanyDesignation
Neil Binoy Palkhiwala09509122Aryav Superspeciality Hospital LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Aryav Superspeciality Hospital Llp
Premium access

Shareholding and investment profile for Bindi Binoy Palkhiwala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bindi Binoy Palkhiwala

Bindi Binoy Palkhiwala currently holds 1 directorship: Aryav Superspeciality Hospital Llp (Designated Partner, since 20 Jul 2022).

Bindi Binoy Palkhiwala was first appointed on 20 Jul 2022 as Designated Partner at Aryav Superspeciality Hospital Llp.

The current boards of Bindi Binoy Palkhiwala's companies include Neil Binoy Palkhiwala (Aryav Superspeciality Hospital Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available